Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'fMet-Leu-Phe receptor' and Ligand = 'BDBM497412'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM497412 (US11008301, Example 104) Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(nc2)N2C[C@@H]3CC[C@H](C2)O3)cc1 |r| Show InChI InChI=1S/C24H26F3N5O3/c25-24(26,27)15-3-5-16(6-4-15)29-23(34)30-20-2-1-11-32(22(20)33)17-7-10-21(28-12-17)31-13-18-8-9-19(14-31)35-18/h3-7,10,12,18-20H,1-2,8-9,11,13-14H2,(H2,29,30,34)/t18-,19+,20-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	630	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US11008301 (2021) BindingDB Entry DOI: 10.7270/Q2HX1GTH
					More data for this Ligand-Target Pair